Structure-activity relationships in platelet-activating factor (PAF) .7. Tetrahydrofuran derivatives as dual PAF antagonists and acetylcholinesterase inhibitors. Synthesis and PAF-antagonistic activity

被引:0
|
作者
LeTexier, L
Favre, E
Redeuilh, C
Blavet, N
Bellahsene, T
Dive, G
Pirotzky, E
Godfroid, JJ
机构
[1] UNIV PARIS 07,UNITE RECH CHIM & PHARMACOL,LAB PHARMACOCHIM MOL,F-75251 PARIS,FRANCE
[2] INST HENRI BEAUFOUR,F-92350 LE PLESSIS ROBINS,FRANCE
[3] UNIV LIEGE,INGN PROT LAB,INST CHIM,LIEGE,BELGIUM
来源
关键词
tetrahydrofuran; PAF antagonist; structure-activity relationship;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
2,5-Disubstituted tetrahydrofuran derivatives present a dual activity: they are effective PAF antagonists and acetylcholinesterase inhibitors. In this paper their synthesis and in vitro PAF-antagonistic effect are described. Introduction in position 2 of a long aliphatic chain bearing a carbamate group and a pyridinium moiety appears to be required for potent platelet aggregation inhibition, Substitution in position 5, or cis-trans isomerism do not induce any increase in activity. No correlation can be established between global lipophilicity and the anti-aggregant activity. Structural requirements for a potent activity are discussed and are consistent with the hypothesis we have proposed for the PAF receptor considered as a multipolarized structure with alternants of electropositive, electronegative and hydrophobic areas.
引用
收藏
页码:189 / 205
页数:17
相关论文
共 50 条
  • [11] PLATELET-ACTIVATING FACTOR (PAF) ENHANCES TUMOR NECROSIS FACTOR PRODUCTION BY ALVEOLAR MACROPHAGES - PREVENTION BY PAF RECEPTOR ANTAGONISTS AND LIPOXYGENASE INHIBITORS
    DUBOIS, C
    BISSONNETTE, E
    ROLAPLESZCZYNSKI, M
    JOURNAL OF IMMUNOLOGY, 1989, 143 (03): : 964 - 970
  • [12] BIOSYNTHESIS OF PAF-ACETHER (PLATELET-ACTIVATING FACTOR) .7. PRECURSORS OF PAF-ACETHER AND ACETYL-TRANSFERASE ACTIVITY IN HUMAN-LEUKOCYTES
    JOUVINMARCHE, E
    NINIO, E
    BEAURAIN, G
    TENCE, M
    NIAUDET, P
    BENVENISTE, J
    JOURNAL OF IMMUNOLOGY, 1984, 133 (02): : 892 - 898
  • [13] Platelet-activating factor (PAF) and PAF acetylhydrolase activity in rat uterus and placenta during the late stages of pregnancy
    Matsubara, T
    Yasuda, K
    Johnston, JM
    Sanezumi, M
    Okada, H
    Matsuoka, S
    Kanzaki, H
    BIOLOGY OF REPRODUCTION, 1997, 56 (04) : 885 - 890
  • [14] A NOVEL CLASS OF PLATELET-ACTIVATING-FACTOR (PAF) ANTAGONISTS .1. SYNTHESIS AND STRUCTURE ACTIVITY STUDIES ON PAF-SULFONAMIDE ISOSTERES
    TSURI, T
    HAGA, N
    MATSUI, T
    KAMATA, S
    KAKUSHI, H
    UCHIDA, K
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1992, 40 (01) : 75 - 84
  • [15] TRIAZOLODIAZEPINES - DISSOCIATION OF THEIR PAF (PLATELET-ACTIVATING-FACTOR) ANTAGONISTIC AND CNS ACTIVITY
    CASALSSTENZEL, J
    WEBER, KH
    BRITISH JOURNAL OF PHARMACOLOGY, 1987, 90 (01) : 139 - 146
  • [16] STRUCTURE-ACTIVITY-RELATIONSHIPS IN PLATELET-ACTIVATING-FACTOR (PAF) .5. SYNTHESIS AND INVITRO ANTAGONISTIC ACTIVITIES OF KETOPHOSPHONATES
    FURNODEWINTER, A
    BROQUET, C
    HAELTERS, JP
    MASSICOT, F
    STURTZ, G
    GODFROID, JJ
    JOURNAL OF LIPID MEDIATORS, 1991, 3 (03): : 289 - 300
  • [17] Platelet-activating factor (PAF)-like activity, localization of PAF receptor (PAF-R) and PAF-acetylhydrolase (PAF-AH) activity in bovine endometrium at different stages of the estrous cycle and early pregnancy
    Tiemann, U
    Tomek, W
    Schneider, F
    Wollenhaupt, K
    Kanitz, W
    Becker, F
    Pöhland, R
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2001, 65 (2-3) : 125 - 141
  • [18] AN ANTAGONISTIC ACTIVITY OF ETIZOLAM ON PLATELET-ACTIVATING-FACTOR (PAF) - INVITRO EFFECTS ON PLATELET-AGGREGATION AND PAF RECEPTOR-BINDING
    MIKASHIMA, H
    TAKEHARA, S
    MURAMOTO, Y
    KHOMARU, T
    TERASAWA, M
    TAHARA, T
    MARUYAMA, Y
    JAPANESE JOURNAL OF PHARMACOLOGY, 1987, 44 (04): : 387 - 391
  • [19] Platelet-activating factor (PAF) receptor binding activity of the roots of Enicosanthellum pulchrum
    Nordin, Noraziah
    Jalil, Juriyati
    Jantan, Ibrahim
    Murad, Shahnaz
    PHARMACEUTICAL BIOLOGY, 2012, 50 (03) : 284 - 290
  • [20] Platelet-activating factor (PAF) and activity of its enzymes in heart failure patients
    Detopoulou, P.
    Nomikos, T.
    Fragopoulou, E.
    Antonopoulou, S.
    Panagiotakos, D.
    Kotrogiannis, I.
    Chrysohoou, C.
    Pitsavos, C.
    Stefanadis, C.
    FEBS JOURNAL, 2008, 275 : 341 - 341